Research at MSK Our research impact Research topics Core facilities & resources ...

Find more on who to contact with questions about your bills, co-pays, or coverage. We are here to help you answer your financial questions.

If you are a cancer patient at MSK and do not have health insurance or are worried that your health insurance may not cover your hospital bill in full, we may be able offer financial assistance to ...

This resource explains steroid-induced hyperglycemia and the signs and symptoms to watch for. It also explains when to check for hyperglycemia, and tips to help manage blood glucose (blood sugar).

If you take medicine for weight loss (such as a GLP-1 medicine), talk with the healthcare provider doing your procedure. Ask them what to do before your procedure. You may need to stop taking it, ...

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial giant cell tumor, based on a trial led by an MSK researcher.

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

The FDA has granted full approval for an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials ...

Your immune system is your body’s defense against infection and disease. All vaccine injections (shots) work by training your immune system to defend your body against things that can harm you.

Targeting the nectin-4 protein in bladder cancer On a search-and-destroy mission, enfortumab vedotin binds to a protein on cancer cells called nectin-4 and delivers a chemotherapy drug called ...